Pulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment

2000 • 2,535 citations

Changes in the normal maximal expiratory flow-volume curve with growth and aging.

1983 • 1,975 citations

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

1998 • 1,037 citations

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity

2005 • 933 citations

Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis

2006 • 828 citations

Predicting Survival in Idiopathic Pulmonary Fibrosis

2001 • 822 citations

Idiopathic Pulmonary Fibrosis

2003 • 615 citations

The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis

2005 • 601 citations

Fibrotic Idiopathic Interstitial Pneumonia

2003 • 562 citations

Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis

2005 • 404 citations

Isolated diffusing capacity reduction in systemic sclerosis

1992 • 237 citations

Combined cryptogenic fibrosing alveolitis andemphysema: the value of high resolution computed tomography in assessment

1990 • 222 citations

Analyses of Efficacy End Points in a Controlled Trial of Interferon-γ1b for Idiopathic Pulmonary Fibrosis

2005 • 217 citations

Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease

2005 • 147 citations

Cryptogenic fibrosing alveolitis with preserved lung volumes

1997 • 137 citations

Pulmonary Emphysema followed by Pulmonary Fibrosis of Undetermined Cause

1993 • 66 citations

The Lung in Systemic Sclerosis

2005 • 64 citations